BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 31178419)

  • 1. Bacterial adhesion and host cell factors leading to effector protein injection by type III secretion system.
    Bohn E; Sonnabend M; Klein K; Autenrieth IB
    Int J Med Microbiol; 2019 Jul; 309(5):344-350. PubMed ID: 31178419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia adhesin A (YadA)--beauty & beast.
    Mühlenkamp M; Oberhettinger P; Leo JC; Linke D; Schütz MS
    Int J Med Microbiol; 2015 Feb; 305(2):252-8. PubMed ID: 25604505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of β1 integrins and bacterial adhesins for Yop injection into leukocytes in Yersinia enterocolitica systemic mouse infection.
    Deuschle E; Keller B; Siegfried A; Manncke B; Spaeth T; Köberle M; Drechsler-Hake D; Reber J; Böttcher RT; Autenrieth SE; Autenrieth IB; Bohn E; Schütz M
    Int J Med Microbiol; 2016 Feb; 306(2):77-88. PubMed ID: 26718660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia enterocolitica exploits different pathways to accomplish adhesion and toxin injection into host cells.
    Keller B; Mühlenkamp M; Deuschle E; Siegfried A; Mössner S; Schade J; Griesinger T; Katava N; Braunsdorf C; Fehrenbacher B; Jiménez-Soto LF; Schaller M; Haas R; Genth H; Retta SF; Meyer H; Böttcher RT; Zent R; Schütz M; Autenrieth IB; Bohn E
    Cell Microbiol; 2015 Aug; 17(8):1179-204. PubMed ID: 25678064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Labeling Enzyme Tags for Analyses of Translocation of Type III Secretion System Effector Proteins.
    Göser V; Kommnick C; Liss V; Hensel M
    mBio; 2019 Jun; 10(3):. PubMed ID: 31239375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesins of human pathogens from the genus Yersinia.
    Leo JC; Skurnik M
    Adv Exp Med Biol; 2011; 715():1-15. PubMed ID: 21557054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins.
    Tejeda-Dominguez F; Huerta-Cantillo J; Chavez-Dueñas L; Navarro-Garcia F
    mBio; 2017 Mar; 8(2):. PubMed ID: 28351918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biogenesis and function of the autotransporter adhesins YadA, intimin and invasin.
    Leibiger K; Schweers JM; Schütz M
    Int J Med Microbiol; 2019 Jul; 309(5):331-337. PubMed ID: 31176600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic
    Morgan JM; Lam HN; Delgado J; Luu J; Mohammadi S; Isberg RR; Wang H; Auerbuch V
    Front Cell Infect Microbiol; 2018; 8():404. PubMed ID: 30524970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling neutrophil-
    Mecsas J
    F1000Res; 2019; 8():. PubMed ID: 31327994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topological Analysis of the Type 3 Secretion System Translocon Pore Protein IpaC following Its Native Delivery to the Plasma Membrane during Infection.
    Russo BC; Duncan JK; Goldberg MB
    mBio; 2019 May; 10(3):. PubMed ID: 31138750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia infection tools-characterization of structure and function of adhesins.
    Mikula KM; Kolodziejczyk R; Goldman A
    Front Cell Infect Microbiol; 2012; 2():169. PubMed ID: 23316485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
    Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake.
    Heise T; Dersch P
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3375-80. PubMed ID: 16488979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Yersinia enterocolitica Effector Translocation into Host Cells Using Beta-lactamase Effector Fusions.
    Wolters M; Zobiak B; Nauth T; Aepfelbacher M
    J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate filaments enable pathogen docking to trigger type 3 effector translocation.
    Russo BC; Stamm LM; Raaben M; Kim CM; Kahoud E; Robinson LR; Bose S; Queiroz AL; Herrera BB; Baxt LA; Mor-Vaknin N; Fu Y; Molina G; Markovitz DM; Whelan SP; Goldberg MB
    Nat Microbiol; 2016 Mar; 1():16025. PubMed ID: 27572444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.